Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.

Savan K Patel, Margaret M Billingsley, Caitlin Frazee, Xuexiang Han, Kelsey L Swingle, Jingya Qin, Mohamad-Gabriel Alameh, Karin Wang, Drew Weissman, Michael J Mitchell

Journal of controlled release : official journal of the Controlled Release Society 2022 Jul

filter terms:

Delivery of nucleic acids, such as mRNA, to immune cells has become a major focus in the past decade with ionizable lipid nanoparticles (LNPs) emerging as a clinically-validated delivery platform. LNPs-typically composed of ionizable lipids, cholesterol, phospholipids, and polyethylene glycol lipids -have been designed and optimized for a variety of applications including cancer therapies, vaccines, and gene editing. However, LNPs have only recently been investigated for delivery to T cells, which has various therapeutic applications including the engineering of T cell immunotherapies. While several LNP formulations have been evaluated for mRNA delivery, recent work has demonstrated that the utilization of cholesterol analogs may enhance mRNA delivery. Other studies have shown that cholesterols modified with hydroxyl groups can alter endocytic recycling mechanisms. Here, we engineered a library of LNPs incorporating hydroxycholesterols to evaluate their impact on mRNA delivery to T cells by leveraging endosomal trafficking mechanisms. Substitution of 25% and 50% 7α-hydroxycholesterol for cholesterol in LNPs enhanced mRNA delivery to primary human T cells ex vivo by 1.8-fold and 2.0-fold, respectively. Investigation of endosomal trafficking revealed that these modifications also increase late endosome production and reduce the presence of recycling endosomes. These results suggest that hydroxyl modification of cholesterol molecules incorporated into LNP formulations provides a mechanism for improving delivery of nucleic acid cargo to T cells for a range of immunotherapy applications. Copyright © 2022 Elsevier B.V. All rights reserved.

Citation

Savan K Patel, Margaret M Billingsley, Caitlin Frazee, Xuexiang Han, Kelsey L Swingle, Jingya Qin, Mohamad-Gabriel Alameh, Karin Wang, Drew Weissman, Michael J Mitchell. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells. Journal of controlled release : official journal of the Controlled Release Society. 2022 Jul;347:521-532